Bal Pharma Limited
BALPHARMA · NSE · Healthcare
StocksWizard rates Bal Pharma Limited a Sell, scoring 40/100 on our blended model. At ₹86.83 it trades below our blended DCF and relative-multiples fair value of ₹173.66, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 10/100 (grade F), with a Piotroski F-score of 3/9. It clears 4 of 12 investability checks, with durability 17, valuation 86 and momentum 88 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹138.93. Low-confidence estimate — limited data.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%7.9%
- ✕Low debt (D/E < 0.5)2.01x
- ✕Positive free cash flow
- ✕Revenue growth > 10%3%
- ✕Earnings growing-34%
- ✕Net margin ≥ 10%2.0%
- ✕Current ratio > 1.51.05
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- –Altman Z in safe zone
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Weaknesses
- •Low return on equity (7.9%).
- •High debt relative to equity.
- •Weak Piotroski score (3/9).
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~100% below our estimated fair value.
Threats
- •Earnings contracting year on year.
About Bal Pharma Limited
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care pro
More in Healthcare
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.